Skip to content

CAP23 Abstract Program

Important Dates to Remember

January 9, 2023

Abstract submission begins at 9:00 AM CT

March 10, 2023

Abstract submission closes at 5:00 PM CT

May 30, 2023

Corresponding authors notified of submission status

August 16, 2023

Top 5 Junior Member Abstract Program winners notified

Program Description

The CAP23 Abstract Program is a competitive program sponsored by the College of American Pathologists. The program is designed to promote a broad range of research in pathology. It offers pathologists and research scientists the opportunity to present original research to their peers in a poster presentation format. Editors from the Archives of Pathology & Laboratory Medicine will evaluate submissions to this program.

In addition, the CAP23 Abstract Program provides a unique opportunity for residents to enhance research skills, develop writing proficiency, gain practical experience at presenting their findings, and contribute to the literature and advancement of pathology. Accepted abstracts and case studies will be published as a web-only supplement to the September 2023 issue of the Archives. CAP junior members who have their abstracts accepted are eligible for cash awards as part of the Top 5 Junior Member Abstract Program.

While the CAP23 meeting offers in-person and virtual registration, submissions accepted for the CAP23 Abstract Program must be presented during in-person poster sessions. A virtual abstract program is not available.

Abstract and case study submissions are now being accepted.

CAP23 Abstract Program Evaluation Criteria

Abstracts will be evaluated on the following criteria:

  • Significance of the hypothesis
  • Valid conclusion(s)
  • Argument clarity
  • Presentation quality

Important Note: The number of case studies that will be accepted for the CAP23 abstract program will be significantly decreased as compared to past years. Submitting case studies that do not provide new or unique information is strongly discouraged. Case studies that merely report additional cases of a known entity will be rejected.

Case studies must include novel findings, such as the following:

  • A new disease or condition (i.e. not previously reported).
  • A distinctive or unusual presentation of a known disease, with one or more well-documented new findings of special clinical relevance (i.e., potentially applicable to diagnosis, therapy, prognosis, etc.) or that serves to provide new insight into the possible pathogenesis of a disease (hypothesis-generating). The new information might be derived from distinctive morphology and/or ancillary testing.
  • A known disease with a demonstrated new finding using state-of-the-art techniques (immunohistochemical, molecular, 3-dimensional reconstruction, cytogenetics, etc.) relevant to a clearly stated hypothesis.
  • A known disease presenting with a previously undescribed clinically or etiologically relevant association (i.e., a myelodysplastic syndrome associated with a plasma cell dyscrasia, etc.) to heighten awareness of a possible link between entities. Such a link might have been described before in one or more individual case reports, and the addition of a case might help solidify a real association.

Submission Categories

Abstracts and case studies may be submitted to the following categories:

Anatomic Pathology

Autopsy and forensic pathology

Bone and soft tissue pathology

Breast pathology

Cardiovascular pathology

Cytopathology

Dermatopathology

Endocrine pathology

Head, neck, and oral pathology

Ophthalmic pathology

Gastrointestinal and liver pathology

Gynecologic and placental pathology

Kidney and genitourinary pathology

Neuropathology

Pulmonary and mediastinal pathology

Clinical Pathology

Clinical chemistry

Clinical immunology

Hematopathology

Microbiology

Molecular pathology

Transfusion medicine and coagulation

 

Practice Management

Administrative and regulatory affairs

Informatics

Pathology education

Practice management

Quality assurance

Submission Guidelines

Please review the entire submission guidelines using the appropriate link below:

Author Requirements

Corresponding authors must be available to respond to questions about the content of their submissions from the Archives editorial office, especially during the period of April 11 to May 19, 2023. Email addresses for corresponding authors must be active and accessible through August 2023.

Corresponding authors will be notified of their submission status on May 30, 2023. Authors of accepted submissions will receive specific information regarding poster presentation requirements in their acceptance notification email on May 30.

CAP Top 5 Junior Member Abstract Program

Authors of the top 5 accepted abstracts received from CAP junior members will be named as the Top 5 Junior Member Abstract Program award winners and given cash prizes:

  • First place cash award = $1,500
  • Second place cash award = $1,000
  • Third place cash award = $750
  • Fourth and fifth place cash awards are $500 each.

To be eligible for the CAP23 Top 5 Junior Member Abstract Program awards, a CAP junior member must:

  1. Have performed a substantial portion of the research and work involved in the preparation of the abstract;
  2. Be listed as either the first or second author;
  3. Serve as the corresponding author.

Top 5 Junior Member Abstract Program award winners will be notified by August 16, 2023.

Questions

If you have questions about the abstract program, please email contactcenter@cap.org prior to completing your submission. Your questions will be routed to the abstract program coordinator.

Remember, submissions cannot be changed or resubmitted after the submission deadline. Carefully review and spell-check your abstracts and case studies prior to submission.